Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Aspirin After Six Months or One Year of Oral Anticoagulants for the Prevention of Recurrent Venous Thromboembolism in Patients With Idiopathic Venous Thromboembolism. The WARFASA Study.

NCT00222677 is registered in ClinicalTrials.gov with University Of Perugia as lead sponsor.

NCT NCT00222677
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00222677 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Aspirin After Six Months or One Year of Oral Anticoagulants for the Prevention of Recurrent Venous Thromboembolism in Patients With Idiopathic Venous Thromboembolism. The WARFASA Study.
Lead sponsor
University Of Perugia
Phase
Phase 2/3
Overall status
Unknown status
Start date
May 31, 2004
Completion date
Not reported
Enrollment
70 (estimated)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

atherosclerosis, deep venous thrombosis, pulmonary embolism, venous thromboembolism